On July 14, Stryker fell 6.41% in regular trading, trading at $310.00 USD/share, with turnover of $341 million.

On the news front, HCA Healthcare issued a disappointing earnings outlook, sparking concerns over slowing demand across the healthcare industry. Stryker, as a leading medical device company, was notably dragged down by the sector-wide selloff. On the same day, Goldman Sachs lowered its price target on Stryker from $363 to $339 while maintaining a neutral rating, adding further selling pressure. The analyst consensus mean price target stands at $387.44 with an average overweight rating.

Within the Health Care Equipment sector, the broad decline was pronounced. GE Healthcare Technologies fell 5.79%, Intuitive Surgical dropped 4.65%, Medtronic declined 4.64%, Boston Scientific lost 4.59%, and Abbott Laboratories fell 3.0%, reflecting significant contagion effects from the industry-level headwind.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)